Chemours (CC) Stock Price, News & Analysis

Company Overview

Chemours Company (NYSE: CC) is a global chemical enterprise formed in 2015 as a spin-off from DuPont, with a focus on delivering performance chemicals and solutions across a range of end markets. The company develops and manufactures a broad portfolio of products, including titanium dioxide pigments, fluoroproducts, and industrial chemicals. Chemours leverages decades of DuPont heritage and research to maintain a pipeline of advanced materials and technology-driven offerings.

Chemours operates through three primary segments: Titanium Technologies, which supplies high-performance titanium dioxide pigments for coatings, plastics, and paper; Thermal & Specialized Solutions, providing refrigerants and blowing agents for HVACR, refrigeration, and insulation markets; and Advanced Performance Materials, where the company produces fluoropolymers, fluorosurfactants, and other specialty chemicals used in electronics, automotive, and industrial applications. Key products in this segment include low-GWP refrigerants and Teflon™ fluoropolymers, which are critical to high-temperature and corrosion-resistant applications.

The company serves customers in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific region through a network of manufacturing sites, research centers, and distribution partners. This global footprint enables Chemours to respond to regional demand dynamics and regulatory requirements, especially in markets transitioning to environmentally sustainable chemistries. Under the leadership of CEO Mark Vergnano and a seasoned executive team, Chemours continues to prioritize operational excellence, research and development, and sustainability initiatives aimed at reducing greenhouse gas emissions and advancing circular economy solutions.

Key Stats

• Today's Range: $12.70 to $13.16
• 50-Day Range: $9.41 to $12.76
• 52-Week Range: $9.13 to $25.54
• Volume: 3.22 million shs
• Average Volume: 2.46 million shs
• Market Capitalization: $1.90 billion
• P/E Ratio: 63.63
• Dividend Yield: 2.75%
• Price Target: $17.33
• Consensus Rating: Moderate Buy

Chemours Stock Analysis - MarketRank™

Chemours scored higher than 87% of companies evaluated by MarketBeat, and ranked 109th out of 576 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Chemours has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Chemours has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 33.50%

Earnings Growth

Earnings for Chemours are expected to grow by 33.50% in the coming year, from $2.03 to $2.71 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Chemours is 63.63, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.58.

Price to Earnings Ratio vs. Sector

The P/E ratio of Chemours is 63.63, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 94.43.

Price to Book Value per Share Ratio

Chemours has a P/B Ratio of 3.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.65% of the float of Chemours has been sold short.

Short Interest Ratio / Days to Cover

Chemours has a short interest ratio ("days to cover") of 4.

Change versus previous month

Short interest in Chemours has recently increased by 12.39%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Chemours pays a meaningful dividend of 2.75%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Chemours does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Chemours is 175.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Chemours will have a dividend payout ratio of 12.92% next year. This indicates that Chemours will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

9.65% of the float of Chemours has been sold short.

Short Interest Ratio / Days to Cover

Chemours has a short interest ratio ("days to cover") of 4.

Change versus previous month

Short interest in Chemours has recently increased by 12.39%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.68

News Sentiment

Chemours has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Basic Materials companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Chemours this week, compared to 7 articles on an average week.

Search Interest

Only 5 people have searched for CC on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.

MarketBeat Follows

Only 2 people have added Chemours to their MarketBeat watchlist in the last 30 days. This is a decrease of -71% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Chemours insiders have bought more of their company's stock than they have sold. Specifically, they have bought $251,573.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 0.47% of the stock of Chemours is held by insiders.

Percentage Held by Institutions

76.26% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CC Stock Analysis - Frequently Asked Questions

How have CC shares performed this year?

Chemours' stock was trading at $16.90 at the beginning of the year. Since then, CC stock has decreased by 24.7% and is now trading at $12.7250.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) released its quarterly earnings data on Tuesday, May, 6th. The specialty chemicals company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.19 by $0.06. The company's revenue was up .4% on a year-over-year basis.
Read the conference call transcript.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemours investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), AT&T (T), Tesla (TSLA), Chevron (CVX) and JPMorgan Chase & Co. (JPM).

Company Calendar

• Last Earnings: 5/06/2025
• Ex-Dividend for 6/16 Dividend: 5/16/2025
• Record date for 6/16 Dividend: 5/19/2025
• Dividend Payable: 6/16/2025
• Today: 7/03/2025
• Next Earnings (Estimated): 7/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Basic Materials
• Industry: CHEM - DIVERSIFD
• Sub-Industry: Chemicals
• Current Symbol: NYSE:CC
• CIK: 1627223
• Web: www.chemours.com
• Phone: (302) 773-1000
• Fax: N/A
• Employees: 6,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $17.33
• High Stock Price Target: $27.00
• Low Stock Price Target: $13.00
• Potential Upside/Downside: +36.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.56
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.20
• Trailing P/E Ratio: 63.63
• Forward P/E Ratio: 6.27
• P/E Growth: N/A
• Net Income: $86 million
• Net Margins: 0.54%
• Pretax Margin: 0.99%
• Return on Equity: 23.82%
• Return on Assets: 2.07%

Debt

• Debt-to-Equity Ratio: 7.01
• Current Ratio: 1.75
• Quick Ratio: 0.83

Sales & Book Value

• Annual Sales: $5.78 billion
• Price / Sales: 0.33
• Cash Flow: $3.69 per share
• Price / Cash Flow: 3.45
• Book Value: $4.05 per share
• Price / Book: 3.14

Miscellaneous

• Outstanding Shares: 149,670,000
• Free Float: 148,971,000
• Market Cap: $1.90 billion
• Optionable: Optionable
• Beta: 1.65